Oak Harbor Wealth Partners’s iShares Biotechnology ETF IBB Stock Holding History

Oak Harbor Wealth Partners’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$35.8K	Sell	170 -19	-10%	-$3.81K	0.01%	185
2026 Q2	$35.9K	Hold	189	–	–	0.01%	178
2026 Q1	$31.9K	Sell	189 -4	-2%	-$684	0.01%	235
2025 Q4	$32.6K	Buy	193 +4	+2%	+$650	0.01%	230
2025 Q3	$27.3K	Hold	189	–	–	0.01%	225
2025 Q2	$23.9K	Hold	189	–	–	0.01%	221
2025 Q1	$24.2K	Hold	189	–	–	0.01%	228
2024 Q4	$25K	Hold	189	–	–	0.01%	204
2024 Q3	$27.5K	Hold	189	–	–	0.01%	198
2024 Q2	$25.9K	Hold	189	–	–	0.01%	195
2024 Q1	$25.9K	Hold	189	–	–	0.01%	200
2023 Q4	$25.7K	Hold	189	–	–	0.01%	197
2023 Q3	$23.1K	Hold	189	–	–	0.01%	198
2023 Q2	$24K	Hold	189	–	–	0.01%	206
2023 Q1	$24.4K	Hold	189	–	–	0.01%	199
2022 Q4	$24.8K	Hold	189	–	–	0.01%	194
2022 Q3	$22K	Hold	189	–	–	0.01%	190
2022 Q2	$22K	Hold	189	–	–	0.01%	188
2022 Q1	$25K	Hold	189	–	–	0.01%	201
2021 Q4	$29K	Buy	+189	New	+$29.3K	0.01%	206

Other funds holding IBB

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.9B AUM 22.61% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $64.4B AUM 36.06% 1-Year Est. Return

Oak Harbor Wealth Partners's IBB Position: Q3 2026 in Review

Oak Harbor Wealth Partners reduced its iShares Biotechnology ETF (IBB) stake by 10% in Q3 2026, selling an estimated $3.81K and leaving 170 shares worth $35.8K. The position accounts for 0.01% of the portfolio, ranked #185.

Oak Harbor Wealth Partners first reported a position in IBB in Q4 2021 and has held it in 20 quarters since. The position peaked at $35.9K in Q2 2026. 907 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

Oak Harbor Wealth Partners held 170 shares of iShares Biotechnology ETF worth $35.8K as of Q3 2026.
Oak Harbor Wealth Partners sold 19 iShares Biotechnology ETF shares in Q3 2026, an estimated $3.81K.
iShares Biotechnology ETF made up 0.01% of Oak Harbor Wealth Partners's portfolio in Q3 2026, its #185 holding.
Oak Harbor Wealth Partners first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 20 quarters since.
Oak Harbor Wealth Partners's iShares Biotechnology ETF position peaked at $35.9K in Q2 2026.
907 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Oak Harbor Wealth Partners's 13F filing for Q3 2026, filed 30 Oct 2026.